SCHEMBL5769504

SCHEMBL5769504

O=C(O)CC(O)(CC(=O)OC1CNC1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
SLC13A5 Q86YT5 9/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28207743 0.84 ALDH1A1 (0.47) ALDH1A1KDM4ELMNAMAPTALOX15
SCHEMBL3443147 0.80 ALDH1A1 (0.50) ALDH1A1KDM4ELMNAMAPTALOX15
SCHEMBL28991911 0.79 ALDH1A1 (0.48) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL5769500 0.78 ALDH1A1 (0.62) ALDH1A1KDM4ELMNAMAPTALOX15
SCHEMBL985035 0.77 GAA (0.43) ALDH1A1KDM4ELMNAMAPTALOX15
SCHEMBL22745718 0.74 CYP2C19 (0.46) ALDH1A1KDM4ELMNAMAPT
Citric Acid SCHEMBL7744389 0.73 ALDH1A1 (0.75) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL28030414 0.73 ALDH1A1 (0.83) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL8586388 0.73 ALDH1A1 (0.94) ALDH1A1KDM4ELMNAMAPTALOX15
Citric Acid SCHEMBL227914 0.73 ALDH1A1 (0.94) ALDH1A1KDM4ELMNAMAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732893-A2 ALPHA ARYL OR HETEROARYL METHYL BETA PIPERIDINO PROPANAMIDE COMPOUNDS AS ORL1-RECEPTOR ANTAGONIST Pfizer Japan, Inc. (JP) 2006-12-20 EP disclosed
WO-2005092858-A2 ALPHA ARYL OR HETEROARYL METHYL BETA PIPERIDINO PROPANAMIDE COMPOUNDS AS ORL1-RECEPTOR ANTAGONIST PFIZER JAPAN INC. (JP) 2005-10-06 WO disclosed